Novo Nordisk Launches "There's Only One Ozempic" Campaign with Justin Long and John Hodgman
ByAinvest
Tuesday, Jan 20, 2026 9:14 am ET1min read
NVO--
Novo Nordisk introduces the "There's Only One Ozempic" campaign to educate adults with type 2 diabetes about Ozempic's FDA-approved uses. The campaign, featuring Justin Long and John Hodgman, aims to encourage meaningful conversations between consumers and healthcare professionals through an unconventional approach to pharma advertising. The goal is to highlight Ozempic's unique features and differentiate it from other GLP-1s and unapproved compounded "semaglutide".

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet